AAI Pharma/CML expanding HQ, lab in Wilmington
WILMINGTON, N.C. — AAIPharma Services Corp./Cambridge Major Laboratories is expanding its laboratory operation and global headquarters in Wilmington and will create at least 37 new jobs by 2018. The company will invest at least $15.8 million for lab expansion and a new headquarters over the next three years. Additional jobs and investment are anticipated through 2019.
“The company’s success and continued growth in Wilmington highlights the fact that life science businesses are flourishing in every corner of North Carolina,” said Gov. Pat McCrory. “Our state plays an increasingly key role in efforts to pioneer new treatments for people around the world, and this corporate expansion keeps that momentum going.”
AAIPharma/CML has operated in Wilmington for the past 30 years. AAIPharma and Cambridge Major Laboratories joined together in 2013 to form a fully integrated custom development and manufacturing organization. Its capabilities include Active Pharmaceutical Ingredient and drug product development, analytical services, manufacturing and packaging of drugs for every stage of drug development from pre-clinical through to commercial supply.
The company provides a wide array of services and solutions to pharmaceutical, biotech and healthcare companies in the U.S. and Europe. AAI Pharma/CML employs approximately 400 people across North Carolina and also has facilities in South Carolina, New Jersey, Wisconsin, Missouri and The Netherlands.